Bright Minds Biosciences's market cap is currently ―. The company's EPS TTM is $-1.312; its P/E ratio is -0.82; Bright Minds Biosciences is scheduled to report earnings on May 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Dec 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	C$ -2.26M	C$ -2.66M	C$ -4.48M	C$ -4.82M
EBITDA	-	C$ -2.24M	C$ -2.66M	C$ -4.48M	C$ -4.82M
Net Income Common Stockholders	-	C$ -2.34M	C$ -2.66M	C$ -4.49M	C$ -4.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 6.75M	C$ 11.21M	C$ 8.64M	C$ 11.47M	C$ 15.12M
Total Assets	C$ 6.88M	C$ 11.55M	C$ 8.82M	C$ 11.76M	C$ 15.41M
Total Debt	C$ 73.55K	C$ 124.48K	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ -6.67M	C$ -11.09M	C$ -8.64M	C$ -11.47M	C$ -15.12M
Total Liabilities	C$ 280.86K	C$ 582.66K	C$ 385.32K	C$ 1.00M	C$ 489.60K
Stockholders Equity	C$ 6.60M	C$ 10.97M	C$ 8.43M	C$ 10.76M	C$ 14.92M
Cash Flow	-
Free Cash Flow	-	C$ -2.66M	C$ -2.86M	C$ -3.65M	C$ -4.95M
Operating Cash Flow	-	C$ -2.66M	C$ -2.86M	C$ -3.65M	C$ -4.95M
Investing Cash Flow	-	-	-	-	C$ 0.00
Financing Cash Flow	-	C$ 2.25M	C$ 12.00K	C$ 1.68K	C$ 118.25K

Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Income Statement >

Bright Minds Biosciences Debt to Assets

Balance Sheet >

Bright Minds Biosciences Cash Flow

Cash Flow >

Bright Minds Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing